Open access · OA
via Europe PMC
Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial.
Pewowaruk R, Jaeger BC, Hughes TM, Upadhya B, Kitzman DW, Supiano MA, Gepner AD.
JACC. Advances · 2026
Abstract
<h4>Background</h4>Hypertension is a leading cardiovascular disease risk factor. Intensive blood pressure (BP) control reduces cardiovascular disease events but may be limited by treatment-related serious adverse events (SAEs).<h4>Objectives</h4>The purpose of this study was to determine if baseline carotid to femoral pulse wave velocity (PWV)-including the component of structural stiffening, due to remodeling of the vessel wall, and load-dependent stiffening, due to the BP load on the arterial wall-is independently associated with orthostatic hypotension (OH) and SAEs in the SPRINT (Systolic Blood Pressure Intervention Trial).<h4>Methods</h4>SPRINT compared intensive (<120 mm Hg) vs standard (<140 mm Hg) systolic BP goals. Carotid-femoral PWV was measured in 642 participants at baseline. Structural stiffening and load-dependent stiffening were calculated by adjusting PWV to a 120/80 mm Hg reference BP with participant-specific models. The association of PWV with OH and with other SAEs was assessed using negative binomial regression.<h4>Results</h4>Over a 3.0-year median follow-up, the cumulative SAE incidence was 38.7% in the intensive group and 35.1% in the standard group. OH was the most frequent event (27.0% standard; 24.4% intensive). Higher load-dependent PWV was associated with greater numbers of OH events (P = 0.005) regardless of treatment group. Higher total PWV was associated with greater rates of SAEs (P = 0.001) and this was largely driven by the association with load-dependent PWV (P < 0.001).<h4>Conclusions</h4>Load-dependent stiffness is associated with SAEs, including OH, regardless of BP treatment intensity. Load-dependent PWV may serve as a valuable clinical tool to identify patients who require enhanced surveillance before initiating intensive BP treatment. (Systolic Blood Pressure Intervention Trial SPRINT]; NCT01206062).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.jacadv.2026.102734
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
R, P., BC, J., TM, H., B, U., DW, K., MA, S., & AD., G. (2026). Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial. <em>JACC. Advances</em>. https://doi.org/10.1016/j.jacadv.2026.102734
Vancouver
R P, BC J, TM H, B U, DW K, MA S, et al. Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial. JACC. Advances. 2026. doi:10.1016/j.jacadv.2026.102734.
BibTeX
@article{pewowaruk2026Arteri,
title = {Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial.},
author = {Pewowaruk R and Jaeger BC and Hughes TM and Upadhya B and Kitzman DW and Supiano MA and Gepner AD.},
journal = {JACC. Advances},
year = {2026},
doi = {10.1016/j.jacadv.2026.102734},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer's & dementia : the journal of the Alzheimer's Association 2026
Open access · OA
Changes in arterial stiffness under blood pressure control are independently associated with cognitive impairment: The Systolic Blood Pressure Intervention Trial (SPRINT).
The Journals of Gerontology Series A 2023
Open access · CC-BY
Proteomic Analysis of the Senescence-Associated Secretory Phenotype: GDF-15, IGFBP-2, and Cystatin-C Are Associated With Multiple Aging Traits
Metabolites 2019
Open access · CC-BY
Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells
Nature Communications 2016
Open access · CC-BY
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Biomolecules 2019
Open access · CC-BY
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
Frontiers in Nutrition 2021
Open access · CC-BY